STARTUP PROFILE

Subsense Inc

COUNTRY
USA
FOUNDED
2024
CATEGORY
Brain-Computer Interface
Developing the first non-surgical, nanoparticle-based bidirectional BCI, enabling precise brain stimulation and recording without surgery.
Visit website →
Neurofounders Insights
$   Funding   -
Series A
MODALITY
Others
FORM FACTOR
Implant
INTERFACE DEPTH
Minimally invasive
INDICATION
Multi-indication
TARGET USER
Patients
REGULATORY STAGE
Preclinical
Subsense is one of the more speculative BCI entrants, proposing a nanoparticle-based, non-surgical bidirectional interface that would bypass conventional implant limitations. If feasible it would be category-defining, but at present it sits firmly in high-risk frontier science.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
Subsense Inc